About: Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 20 July 2007

Attributes	Values
rdf:type	Item
description	article científic (ca) article scientific (oc) articol științific (ro) articolo scientifico (it) artigo científico (gl) artikull shkencor (sq) artikulong pang-agham (tl) artykuł naukowy (pl) bilimsel makale (tr) mokslinis straipsnis (lt) scienca artikolo (eo) teaduslik artikkel (et) tieteellinen artikkeli (fi) tudományos cikk (hu) vedecký článok (sk) vetenskaplig artikel (sv) vitenskapelig artikkel (nb) vitskapeleg artikkel (nn) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) επιστημονικό άρθρο (el) мақолаи илмӣ (tg) научна статия (bg) научная статья (ru) научни чланак (sr) מאמר מדעי (he) სამეცნიერო სტატია (ka) บทความทางวิทยาศาสตร์ (th) bài báo khoa học (vi) naučni članak (sr-el) мақолаи илмӣ (tg-cyrl) научни чланак (sr-ec) գիտական հոդված (hy) سائنسی مضمون (ur) مقالهٔ علمی (fa) artículu científicu espublizáu en 2007 (ast) 2007 nî lūn-bûn (nan) 2007年の論文 (ja) 2007년 논문 (ko) artigo científico (publicado na 2007) (pt) artigo científico (publicado na 2007) (pt-br) artículo científico publicado en 2007 (es) ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ (bn) наукова стаття, опублікована в липні 2007 (uk) 2007年学术文章 (zh-cn) 2007年学术文章 (zh-sg) 2007年学术文章 (zh-hans) 2007年学术文章 (wuu) 2007年学术文章 (zh-my) 2007年學術文章 (zh) 2007年學術文章 (zh-hk) 2007年學術文章 (zh-tw) 2007年學術文章 (zh-hant) 2007年學術文章 (yue) 2007年學術文章 (zh-mo) article scientifique publié en 2007 (fr) videnskabelig artikel (udgivet 2007) (da) مقالة علمية نشرت في 20 يوليو 2007 (ar) scientific article published on 20 July 2007 (en)
publication date	wds:Q37367847-C1EB3EE7-5E9C-42AA-A5BA-EC8CF4D1603C
publication date	2007-07-20 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37367847-96C02B86-937D-43CF-9C55-9DC7F6C10E25
language of work or name	English
cites work	wds:Q37367847-0E49B07D-EA0D-41CA-842F-F397D02A2598 wds:Q37367847-1204ADC8-1B16-46D2-AE19-2C900A410756 wds:Q37367847-187D00FE-169A-4618-98E7-09DD60B2B065 wds:Q37367847-23F56CED-72FA-4FBE-B9BC-2468556AD547 wds:Q37367847-33B9A223-B784-44F7-B294-E10918002BF7 wds:Q37367847-3A2D5448-DDBE-44B6-BF7B-C1DE36E9AC1A wds:Q37367847-3C56F792-01B7-4BC7-999A-41B60EB37F80 wds:Q37367847-4BFE68C1-BD26-45B9-9720-2C8005DA67CC wds:Q37367847-592AF951-8699-4FD2-B426-1F07CA280CFE wds:Q37367847-74F2F8AE-9B9A-4E4E-9723-E56B0060FF20 wds:Q37367847-7753A4C9-694C-473F-8F77-8394FCA9F1CA wds:Q37367847-7EE7833B-04BB-4150-A5F7-B450D077E931 wds:Q37367847-98AACBA2-F8F4-4971-95FD-23F230E523DF wds:Q37367847-BD7FE0FD-04BF-4BDC-96D7-44E920761863 wds:Q37367847-C46D06D9-F099-4970-BE5B-3385C51E906F wds:Q37367847-F1FA9611-EDBC-481E-B8CE-E846E9974F3D
cites work	B-cell targeting in rheumatoid arthritis and other autoimmune diseases Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis Do self-perpetuating B lymphocytes drive human autoimmune disease? Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis Lymphoid neogenesis in rheumatoid synovitis Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy Quantitative biomarker analysis of synovial gene expression by real-time PCR Therapeutic B cell depletion and regeneration in rheumatoid arthritis: emerging patterns and paradigms Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes Effective B cell depletion with rituximab in the treatment of autoimmune diseases The case for confidence intervals in controlled clinical trials
author name string	wds:Q37367847-0BDA24DB-5A11-42A8-8B27-8610EF7E28AC wds:Q37367847-36535AFC-9637-4651-8461-6D2A36387F49 wds:Q37367847-49FF2D8F-1DDB-4ACF-B756-505F98986ECD

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software